63 results
DEFA14A
KPRX
Kiora Pharmaceuticals Inc
1 Sep 23
Additional proxy soliciting materials
7:00am
, Kiora Pharmaceuticals, Inc. (the “Company”) called to order a Special Meeting of Stockholders (the “Special Meeting”). At the Special Meeting, there were … the Special Meeting until September 27, 2023 at 8:30 a.m. Pacific Time. At that time, the Special Meeting will be reconvened at the offices of Kiora
8-K
EX-99.1
KPRX
Kiora Pharmaceuticals Inc
1 Sep 23
Kiora Pharmaceuticals Adjourns Special Meeting of Stockholders to September 27
7:00am
Exhibit 99.1
Kiora Pharmaceuticals Adjourns Special Meeting of Stockholders to September 27
Encinitas, CA – September 1, 2023 -- Kiora … Pharmaceuticals, Inc. (NASDAQ: KPRX) (“Kiora” or the “Company”) announced that the Company’s Special Meeting of Stockholders (the “Special Meeting”) held
8-K
omg4 5aw8l7dl
16 Sep 22
Kiora Pharmaceuticals Appoints Melissa Tosca as Executive Vice President of Finance
4:30pm
DEFA14A
EX-99.1
uea ju4wu8t0y
1 Sep 23
Additional proxy soliciting materials
7:00am
8-K
ys2auv3m3x6
1 Sep 23
Kiora Pharmaceuticals Adjourns Special Meeting of Stockholders to September 27
7:00am
DRS/A
EX-3.4
kfmppn7cod
8 Jul 14
Draft registration statement (amended)
12:00am
8-K
0xk3l363uc9jkmc
27 Sep 23
Submission of Matters to a Vote of Security Holders
7:06pm
8-K
EX-3.2
jv0zyb0q4nuqu0 xan
20 Feb 15
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
EX-3.1
qo5z 3k1qkg3s3p
4 Aug 22
Amendments to Articles of Incorporation or Bylaws
4:36pm
8-K
EX-3.2
z6q3ifw6bn26z51v2
8 Nov 21
EyeGate is Now Kiora Pharmaceuticals; Provides Update on Company’s
7:32am
8-K
EX-99.1
6flnwm8wkjw
21 Sep 23
Kiora Pharmaceuticals Appoints Praveen Tyle, PhD, as New Chairman; Succeeds Paul Chaney Who is Retiring After Serving 17 Years
7:00am
DRS/A
EX-3.3
fa55qe8dt
8 Jul 14
Draft registration statement (amended)
12:00am
8-K
EX-3.1
ajjh854i 3n9
20 Feb 15
Amendments to Articles of Incorporation or Bylaws
12:00am